Results 181 to 190 of about 162,494 (358)

Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin. [PDF]

, 1989
PJ Prichard, GK Kitchingman, R P Walt, T K Daneshmend, C J Hawkey   +4 more
openalex   +1 more source

INTERACTIONS WITH WARFARIN [PDF]

British Journal of Clinical Pharmacology, 1974
openaire   +3 more sources

The impact of socio‐economic deprivation on the long‐term survival of people with diabetes and acute myocardial infarction: A nationwide cohort study

Diabetic Medicine, Volume 42, Issue 11, November 2025.
Graphical Abstract summarising key study findings. Abstract Background People from areas of socio‐economic deprivation have poorer outcomes following acute myocardial infarction (AMI). How deprivation influences the survival of people with diabetes mellitus (DM) post‐AMI is not well described.
Nicholas Weight, Andrew Cole, Muhammad Rashid, Kamlesh Khunti, Shivani Misra, Evangelos Kontopantelis, Thomas A. Shepherd, Martin K. Rutter, Mamas A. Mamas   +8 more
wiley   +1 more source

Drug interactions with carbamazepine: a case study of influence on anticoagulation treatment with warfarin

Zdravniški Vestnik, 2007
Background: Drug interactions are an important segment of drug related problems. Therefore their evaluation should be an integral component of patient management, especially in elderly patients who often receive multiple medications.
Iztok Grabnar, Igor Locatelli, Darja Herman, Polona Peternel, Mojca Stegnar, Mitja Lainščak, Katja Breskvar, Vita Dolžan, Aleš Mrhar   +8 more
doaj  

Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy [PDF]

, 1987
JP Miletich, GJ Jr Broze
openalex   +1 more source

Lower risk of cardiovascular events in patients initiated on semaglutide 2.4 mg in the real‐world: Results from the SCORE study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World)

Diabetes, Obesity and Metabolism, Volume 27, Issue 11, Page 6691-6704, November 2025.
Abstract Aims In this first interim analysis of the SCORE study, we investigated the risk of major adverse cardiovascular events (MACE) among individuals with atherosclerotic cardiovascular disease (ASCVD) and overweight/obesity but without diabetes who initiated semaglutide 2.4 mg in real‐world settings.
Kim G. Smolderen, Carlos Mena‐Hurtado, Zhenxiang Zhao, Wojciech Michalak, Mads Faurby, B. Gabriel Smolarz, Mikhail N. Kosiborod, Jinlin Song, Yan Chen, Joanna Boland, Michael G. Nanna   +10 more
wiley   +1 more source

Stereoselective interaction between the R enantiomer of warfarin and cimetidine. [PDF]

, 1986
IA Choonara, S. Cholerton, BP Haynes, AM Breckenridge, BK Park   +4 more
openalex   +1 more source

Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? [PDF]

, 2014
Al-Khatib, SM, Banerjee, A, Blendea, D, Camm, AJ, Conroy, JM, Cosio, FG, De Bono, J, G Cosio, MD, Guasch, E, Halperin, JL, Hess, PL, Kirchhof, P, Lip, GY, Nattel, S, Ruskin, J, Savelieva, I   +15 more
core   +1 more source

Patient Characteristics, Healthcare Contacts and Drug Use in Polycythaemia Vera in Denmark

European Journal of Haematology, Volume 115, Issue 5, Page 474-483, November 2025.
ABSTRACT Objective Patients with polycythaemia vera (PV) may experience symptoms and cardiovascular complications before receiving a diagnosis. Understanding the associated patterns of healthcare and drug utilisation may help detect patients who need diagnostic workup.
Karoline Mathilde Lundgaard, Dustin Andersen Patel, Mette Brabrand, Christen Lykkegaard Andersen, Anton Pottegård   +4 more
wiley   +1 more source

A simple formula for predicting the warfarin dose in atrial fibrillation: development, external validation, and model comparison. [PDF]

Thromb J
Ujjin A, Pongbangli N, Wongcharoen W, Suwanagool A, Chai-Adisaksopha C.   +4 more
europepmc   +1 more source